Glycine Transporter Type-1 and its Inhibitors
Journal:
Current Medicinal Chemistry
Volume:
13
Page:
1017-1044
Author(s):
L. G. Harsing Jr., Z. Juranyi, I. Gacsalyi, P. Tapolcsanyi, A. Czompa and P. Matyus
Neuropeptide Y: Role in Emotion and Alcohol Dependence
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
5
Page:
181-195
Author(s):
R. Quirion, Y. Dumont and C. Carvajal
QSAR Studies on Blood-Brain Barrier Permeation
Journal:
Current Computer-Aided Drug Design
Volume:
2
Page:
31-55
Author(s):
Juan M. Luco and Eduardo Marchevsky
Effects of Eugenol on the Central Nervous System: Its Possible Application to Treatment of Alzheimers Disease, Depression, and Parkinsons Disease
Journal:
Current Bioactive Compounds
Volume:
2
Page:
57-66
Author(s):
Yoshifumi Irie
The Molecular Genetics of Migraine: Toward the Identification of Responsible Genes
Journal:
Current Genomics
Volume:
7
Page:
1-10
Author(s):
Fernando Gianfrancesco and Teresa Esposito
Neurosteroids in the Brain Neuron: Biosynthesis, Action and Medicinal Impact on Neurodegenerative Disease
Journal:
Central Nervous System Agents in Medicinal Chemistry
Volume:
6
Page:
73-82
Author(s):
Kazuyoshi Tsutsui and Synthia H. Mellon
Pharmacogenetics of Cytochrome P450 (CYP) 1A2 and Variability in Psychotropic Drug Response
Journal:
Current Psychiatry Reviews
Volume:
2
Page:
77-94
Author(s):
Juan A. Carrillo and Guillermo Gervasini
Fatty Acid Amide Hydrolase: A Potential Target for Next Generation Therapeutics
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
759-772
Author(s):
Mauro Maccarrone
Targeting Exocytosis: Ins and Outs of the Modulation of Quantal Dopamine Release
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
5
Page:
57-77
Author(s):
Remco H.S. Westerink
Headache: One of the Most Common and Troublesome Adverse Reactions to Drugs
Journal:
Current Drug Safety
Volume:
1
Page:
43-58
Author(s):
Anna Ferrari